Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
Phase 1 Recruiting
24 enrolled
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
Phase 1 Recruiting
200 enrolled
MOUNTAINEER-03
Phase 3 Recruiting
400 enrolled
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Phase 1 Recruiting
914 enrolled
MK-3475-C66
Phase 3 Recruiting
100 enrolled
TRIBE-C
Phase 3 Recruiting
528 enrolled
HARMONi-GI3
Phase 3 Recruiting
600 enrolled
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Phase 3 Recruiting
408 enrolled
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
Phase 1 Recruiting
330 enrolled
EGRET
Phase 1 Recruiting
403 enrolled
CAPRI-3 GOIM
Phase 3 Recruiting
480 enrolled
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Phase 1/2 Recruiting
220 enrolled
MK-9999-02A
Phase 1/2 Recruiting
220 enrolled
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Phase 2 Recruiting
144 enrolled
CANTOR
Phase 2 Recruiting
120 enrolled
5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
Phase 1/2 Recruiting
27 enrolled
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
Phase 1 Recruiting
84 enrolled
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
260 enrolled
CEIL
Phase 2 Recruiting
198 enrolled
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Phase 1/2 Recruiting
440 enrolled
AIO-KRK-0418
Phase 3 Recruiting
507 enrolled
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Phase 1 Recruiting
49 enrolled
AtezoTRIBE2
Phase 3 Recruiting
238 enrolled
LIBImAb
Phase 3 Recruiting
280 enrolled
Trial of ProAgio in Advanced/Metastatic Colorectal Cancer
Phase 1 Recruiting
27 enrolled
OPTICAL-2
Phase 2 Recruiting
143 enrolled
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Phase 2 Recruiting
582 enrolled
OSCAR
Phase 3 Recruiting
348 enrolled
ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer
Phase 1 Recruiting
560 enrolled
Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer
Phase 2 Recruiting
173 enrolled
A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
Phase 2 Recruiting
130 enrolled
IMPROVE-2
Phase 3 Recruiting
500 enrolled
Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer
Phase 3 Recruiting
340 enrolled